Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms (Q41743797)

8 October 2017

1 reference

title

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms (English)

1 reference

8 October 2017

2

1 reference

8 October 2017

1

Cumming P

1 reference

8 October 2017

1 May 1998

1 reference

8 October 2017

1 reference

8 October 2017

29

1 reference

8 October 2017

1

1 reference

8 October 2017

37-61

1 reference

Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers.

8 October 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Biological imaging and the molecular basis of dopaminergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Positron emission tomography in Shy-Drager syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Biochemical properties and kinetic parameters of dihydroxyphenyialanine – 5-hydroxytryptophan decarboxylase in brain, liver, and adrenals of cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Modulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase after inhibiting monoamine oxidase-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Preparation and properties of a homogeneous aromatic l-amino acid decarboxylase from hog kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Parametric imaging of the rate constant Ki using [18Fluoro]-L-dopa positron emission tomography in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Brain uptake of alpha-[14C]methyl-para-tyrosine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of the living rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Radiobrominated m-tyrosine analog as potential CNS L-dopa pet tracer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Visualization of dopamine nerve terminals by positron tomography using [18F]fluoro-beta-fluoromethylene-m-tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Distribution and kinetics of 3-O-methyl-6-[18F]fluoro-L-dopa in the rhesus monkey brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Presynaptic dopaminergic deficits in Lesch-Nyhan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

18F fluoro-dopa: A unique gamma emitting substrate for Dopa decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Striatal dopamine metabolism in living monkeys examined by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Dopamine visualized in the basal ganglia of living man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Neuronal source of plasma dihydroxyphenylalanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

3-O-methyldopa administration does not alter fluorodopa transport into the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: implications for the symptomatic threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Pyridoxine effect on synthesis rate of serotonin in the monkey brain measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Functional effects of striatal dysfunction in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Rapid decar☐ylation of carbon-11 labelleddl-dopa in the brain: A potential approach for external detection of nervous structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

18F‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

A pre-positron emission tomography study of L-3,4-dihydroxy-[3H]phenylalanine distribution in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Nigrostriatal function in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Assessment of dopamine and its metabolites in the intracellular and extracellular compartments of the rat striatum after peripheral administration of L-[11C]dopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Clinical and [18F] dopa PET findings in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Dopaminergic function in familial Parkinson's disease: A clinical and18F-dopa positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

3-O-methyl metabolites of catecholamines: Automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Striatal function in normal aging: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Striatal dopamine deficiency in Parkinson's disease: role of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Parkinsonism caused by petroleum waste ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Dopaminergic function in patients with posttraumatic parkinsonism: an 18F-dopa PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Increased dopamine activity associated with stuttering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199805%2929%3A1%3C37%3A%3AAID-SYN4%3E3.0.CO%3B2-C

10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9552174